Article
Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses - Cell Death & Differentiation
Rating:
0.0
Views:
29
Likes:
1
Library:
1
Whole-genome screens using CRISPR technologies are powerful tools to identify novel tumour suppressors as well as factors that impact responses of malignant cells to anti-cancer agents. Applying this methodology to lymphoma cells, we conducted a genome-wide screen to identify novel inhibitors of tumour expansion that are induced by the tumour suppressor TRP53.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value